Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.

Scope of the Report:
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for ICAD (Intracranial Atherosclerotic Disease) Pathology is expected to grow at a CAGR of roughly 8.7% over the next five years, will reach 220 million US$ in 2024, from 130 million US$ in 2019, according to a new study.
This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Stryker
Balt
TERUMO
MicroPort
Acandis

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
primarily split into
Stent
PTA Balloon

Market Segment by Applications, can be divided into
Hospital
Clinic
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, with price, sales, revenue and global market share of ICAD (Intracranial Atherosclerotic Disease) Pathology in 2017 and 2018.
Chapter 3, the ICAD (Intracranial Atherosclerotic Disease) Pathology competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the ICAD (Intracranial Atherosclerotic Disease) Pathology breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, ICAD (Intracranial Atherosclerotic Disease) Pathology market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology sales channel, distributors, customers, research findings and conclusion, appendix and data source.